BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6300579)

  • 1. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel.
    Fairhurst AS; Thayer SA; Colker JE; Beatty DA
    Life Sci; 1983 Mar; 32(12):1331-9. PubMed ID: 6300579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity binding sites for [3H]-nitrendipine in rabbit uterine smooth muscle.
    Miller WC; Moore JB
    Life Sci; 1984 Apr; 34(18):1717-24. PubMed ID: 6727544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of [3H]nitrendipine binding and KCl-induced calcium uptake in rat cortical synaptosomes.
    Wei JW; Chiang DH
    Gen Pharmacol; 1985; 16(3):211-6. PubMed ID: 3160632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT; Tremble P
    J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
    Gould RJ; Murphy KM; Snyder SH
    Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
    Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
    J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct photoaffinity labeling of the high affinity nitrendipine-binding site in subcellular membrane fractions isolated from canine myocardium.
    Campbell KP; Lipshutz GM; Denney GH
    J Biol Chem; 1984 May; 259(9):5384-7. PubMed ID: 6325434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic localization of a calcium channel antagonist, [3H]nitrendipine, binding site in rat brain.
    Quirion R
    Neurosci Lett; 1983 Apr; 36(3):267-71. PubMed ID: 6866333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phencyclidine increases the affinity of dihydropyridine calcium channel antagonist binding in rat brain.
    Bolger GT; Rafferty MF; Skolnick P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):227-34. PubMed ID: 2932650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
    J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
    Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
    Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrendipine: effects on vascular responses and myocardial binding.
    McBride W; Mukherjee A; Haghani Z; Wheeler-Clark E; Brady J; Gandler T; Bush L; Buja LM; Willerson JT
    Am J Physiol; 1984 Nov; 247(5 Pt 2):H775-83. PubMed ID: 6093595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]nitrendipine labelling of the Ca2+ channel in skeletal muscle.
    Fosset M; Jaimovich E; Delpont E; Lazdunski M
    Eur J Pharmacol; 1982 Dec; 86(1):141-2. PubMed ID: 6297924
    [No Abstract]   [Full Text] [Related]  

  • 18. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
    Pang DC; Sperelakis N
    Biochem Pharmacol; 1984 Mar; 33(5):821-6. PubMed ID: 6608945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site.
    Zobrist RH; Giacomini KM; Nelson WL; Giacomini JC
    J Mol Cell Cardiol; 1986 Sep; 18(9):963-74. PubMed ID: 3783730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.